ArticleActa clinica Croatica2024
MIGRATION AND MISALIGNMENT OF MYVAL BALLOON EXPANDABLE VALVE DURING TRANSCATETHER AORTIC VALVE IMPLATATION.
Article in Acta clinica Croatica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Transcatheter aortic valve implantation (TAVI) is a treatment method for aortic stenosis with proven efficacy and recommended by professional societies in the cardiovascular field. Complications during TAVI are rare but important and potentially devastating, especially embolization or migration of prothesis. Case presentation: We present a case of an 82-year-old patient in whom the prosthesis was displaced during implantation and later expanded in the descending aorta with a new prosthesis implanted in the aortic valve position. Conclusion: Dislocation of the prosthesis during implantation is a serious complication. In most cases the prosthesis can be repositioned elsewhere in the aorta or perform a valve-in-valve procedure. In case of failure, the availability of cardiac surgery is important. Technological improvements, increasing operator experience and adequate periprocedural preparation minimize the risk of complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.